Parameter | Intermittent preventive treatment in pregnancy | ||||
---|---|---|---|---|---|
Nonea | All | One dose | Two doses | Three doses | |
No. | 53 | 173 | 60 | 59 | 54 |
Age | 24 (17–42) | 27 (16–41)* | 26 (16–40) | 26 (16–40) | 28 (16–41)* |
Primiparae (%) | 41.5 | 30.1 | 35.0 | 27.1 | 27.8 |
Proportion with > 3 ANC visits (%) | 35.3 (18/51) | 65.7* (113/172) | 41.7 | 65.5* (38/58) | 92.6* |
Birth weight (g; median, range) | 2,900 (1,820–4,000) | 3,100 (1,600–5,460) | 3,025 (2,200–5,460) | 3,100 (1,600–4,250) | 3,125 (2,030–4,100) |
LBW (%) | 15.4 (8/52) | 11.6 | 10.0 | 15.3 | 9.3 |
Hb (g/dL; median, range) | 11.5 (7.2–14.5) | 12.1 (7.7–15.9)* | 12.1 (8.4–15.6)* | 11.9 (7.7–14.4) | 12.4 (9.3–15.9)* |
Maternal anaemia (%) | 39.6 | 18.5* | 16.7* | 27.1 | 11.1* |
Fever (%) | 1.9 | 8.1 | 13.3* | 5.1 | 5.6 |
Placental infection (%) | Â | Â | Â | Â | Â |
   Microscopy | 20.8 | 13.3 | 13.3 | 15.3 | 11.1 |
   Pigment | 26.4 | 15.0 | 15.0 | 15.3 | 14.8 |
   HRP2 | 35.8 | 17.9* | 13.3* | 22.0 | 18.5* |
   PCR | 49.1 | 26.6* | 21.7* | 32.2 | 25.9* |